Literature DB >> 15952195

Molecular mediators of metastasis in head and neck squamous cell carcinoma.

Gina M S Howell1, Jennifer R Grandis.   

Abstract

BACKGROUND: The presence of regional metastasis in patients with head and neck squamous cell carcinoma (HNSCC) is a common and adverse event associated with poor prognosis and high mortality. Although significant improvements in standard therapies have increased the efficacy of local tumor management, the high incidence of tumor recurrence has resulted in limited improvements in overall survival rates. Understanding the molecular mechanisms that mediate HNSCC invasion and metastasis may enable identification of novel therapeutic targets for the prevention and management of tumor dissemination.
METHODS: A literature review was performed.
RESULTS: Several biologic mediators and mechanisms that have been implicated in HNSCC metastasis, such as cell adhesion molecules, proteolytic enzymes, growth factor signaling, metastasis suppressor genes, and chemokine receptors were reviewed.
CONCLUSIONS: Prevention of HNSCC metastasis is an important clinical objective that requires an increased understanding of the molecular mechanisms of tumor invasion and dissemination. Copyright 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952195     DOI: 10.1002/hed.20222

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  25 in total

1.  Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic disease.

Authors:  Tovë M Goldson; Yimei Han; Kristen B Knight; Heidi L Weiss; Vicente A Resto
Journal:  J Exp Ther Oncol       Date:  2010

2.  Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.

Authors:  Eben L Rosenthal; Lindsay S Moore; Kiranya Tipirneni; Esther de Boer; Todd M Stevens; Yolanda E Hartman; William R Carroll; Kurt R Zinn; Jason M Warram
Journal:  Clin Cancer Res       Date:  2017-04-26       Impact factor: 12.531

3.  Temporal characterization of lymphatic metastasis in an orthotopic mouse model of oral cancer.

Authors:  Peter Szaniszlo; Susan M Fennewald; Suimin Qiu; Carla Kantara; Tuya Shilagard; Gracie Vargas; Vicente A Resto
Journal:  Head Neck       Date:  2014-01-27       Impact factor: 3.147

Review 4.  Molecular changes in the multistage pathogenesis of head and neck cancer.

Authors:  Brian J Park; Simion I Chiosea; Jennifer R Grandis
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 5.  Biomarkers of head and neck cancer, tools or a gordian knot?

Authors:  Evangeli S Lampri; Georgios Chondrogiannis; Elli Ioachim; Anna Varouktsi; Antigoni Mitselou; Aggeliki Galani; Evangelos Briassoulis; Panagiotis Kanavaros; Vasiliki Galani
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis.

Authors:  Yasusei Kudo; Shinji Iizuka; Maki Yoshida; Takaaki Tsunematsu; Tomoyuki Kondo; Ajiravudh Subarnbhesaj; Elsayed M Deraz; Samadarani B S M Siriwardena; Hidetoshi Tahara; Naozumi Ishimaru; Ikuko Ogawa; Takashi Takata
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

7.  Integration of biomarkers including molecular targeted therapies in head and neck cancer.

Authors:  Michelle D Williams
Journal:  Head Neck Pathol       Date:  2010-02-13

8.  Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.

Authors:  Jinke Xu; Wei Lu; Senlin Zhang; Chuchao Zhu; Tingting Ren; Tong Zhu; Hu Zhao; Yanpu Liu; Jin Su
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

9.  Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.

Authors:  V Häyry; L K Mäkinen; T Atula; H Sariola; A Mäkitie; I Leivo; H Keski-Säntti; J Lundin; C Haglund; J Hagström
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

10.  Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.

Authors:  Oleksandr Ekshyyan; Youhua Rong; Xiaohua Rong; Kavita M Pattani; Fleurette Abreo; Gloria Caldito; John Kai Siung Chang; Federico Ampil; Jonathan Glass; Cherie-Ann O Nathan
Journal:  Mol Cancer Ther       Date:  2009-07-22       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.